title: Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
abstract: Response to: Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev. Vaccines 11(5), 609-628 (2012).
authors.forename: Subhash C
authors.initials: SC
authors.lastname: Arya
authors.forename: Nirmala
authors.initials: N
authors.lastname: Agarwal
mesh_terms: D006801:Humans; D011051:Poliomyelitis / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects*; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects*
chemical_list: D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral